Pharmacoeconomic evaluation of combination therapy with dutasteride and α1 blocker for treatment of benign prostatic hyperplasia in Japan

Pharmacoeconomic evaluation of combination therapy with dutasteride and α1 blocker for treatment of benign prostatic hyperplasia in Japan

The cost-effectiveness of combination therapy with an α1 blocker and dutasteride in benign prostatic hyperplasia (BPH) was analyzed in comparison with α1 blocker monotherapy. A Markov model with seven health states related to BPH was constructed with 4-year and 10-year time horizons and from the ent...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 58(2012), 2 vom: 01. Feb., Seite 61-9
1. Verfasser: Takayama, Tatsuya (VerfasserIn)
Weitere Verfasser: Arakawa, Ichiro, Kakihara, Hiroaki, Tachibana, Keijiro, Ozono, Seiichiro
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Comparative Study English Abstract Journal Article Research Support, Non-U.S. Gov't 5-alpha Reductase Inhibitors Adrenergic alpha-1 Receptor Antagonists Azasteroids Dutasteride O0J6XJN02I